Bharat Biotech debunks 'political pressure' claims regarding authorisation of Covaxin. It asserts that 'scientific approach was followed.'
A recent report by STAT has emerged about Covaxin and its maker, Bharat Biotech. The investigation suggests that the Hyderabad-based Covaxin developer, Bharat Biotech, had skipped some steps of the Central Drug Standards Control Organization (CDSCO).
According to the report, the Covaxin was rushed due to 'political pressure,' and as a result, it skipped various safeguards in the process before making it available for people.
THIS IS A BREAKING STORY. UPDATES SOON
Aurobindo Pharma To Acquire Additional 20% Stake In China JV For $5.12 Million
Over 15 Lakh Taxpayers Revise ITRs For AY 2025-26 Amid I-T Nudge On Bogus Donation Claims
Delhi-NCR Housing Affordability Dips As Prices Surge; Mumbai Improves Below 50% Threshold
EOW Registers FIR Against Former Navi Mumbai APMC Deputy Chairman For ₹57.14 Crore Real Estate Fraud
